Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma-Reference-Cited by-同舟云学术

Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma

Published:2019-04-25 Issue:10 Volume:32 Page:1544-1550
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Eich Marie-Lisa,Rodriguez Pena Maria Del Carmen,Springer Simeon U.,Taheri Diana,Tregnago Aline C.,Salles Daniela C.,Bezerra Stephania Martins,Cunha Isabela W.^ORCID,Fujita Kazutoshi,Ertoy Dilek,Bivalacqua Trinity J.,Tomasetti Cristian,Papadopoulos Nickolas,Kinzler Ken W.,Vogelstein Bert,Netto George J.^ORCID

Funder

Henry and Marsha Laufer, the Virginia and DK Ludwig Fund for Cancer Research, the Commonwealth Foundation, the John Templeton Foundation, and the Conrad R Hilton Foundation

Johns Hopkins Greenberg Bladder Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-019-0276-y.pdf

Reference34 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

2. Netto GJ. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a “mirage”? Adv Anat Pathol. 2013;20:175–203.

3. Chamie K, Litwin MS, Bassett JC, Daskivich TJ, Lai J, Hanley JM, et al. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer. 2013;119:3219–27.

4. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F, Vicente-Rodriguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol. 2000;164:680–4.